X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
l-dopa-induced dyskinesia (144) 144
parkinson's disease (141) 141
neurosciences (120) 120
index medicus (97) 97
animals (89) 89
male (50) 50
movement disorders (49) 49
levodopa - adverse effects (48) 48
phenols (46) 46
basal ganglia (45) 45
parkinsons-disease (45) 45
levodopa-induced dyskinesia (44) 44
rats (44) 44
parkinson disease - drug therapy (43) 43
parkinson’s disease (42) 42
disease models, animal (40) 40
abnormal involuntary movements (38) 38
pharmacology & pharmacy (36) 36
humans (35) 35
rats, sprague-dawley (35) 35
neurology (34) 34
analysis (32) 32
female (32) 32
dopamine (31) 31
levodopa (30) 30
levodopa-induced dyskinesias (30) 30
dyskinesia, drug-induced - drug therapy (28) 28
striatum (28) 28
dopa (27) 27
dyskinesia, drug-induced - physiopathology (27) 27
rat model (26) 26
clinical neurology (25) 25
antiparkinson agents - adverse effects (24) 24
dopa-induced dyskinesia (22) 22
dyskinesia, drug-induced - metabolism (22) 22
l-dopa induced dyskinesia (22) 22
6-hydroxydopamine (21) 21
dyskinesia (21) 21
glutamate (21) 21
oxidopamine (21) 21
antiparkinson agents - pharmacology (19) 19
l-dopa-induced dyskinesias (19) 19
levodopa - therapeutic use (19) 19
neurodegenerative diseases (19) 19
animal models (18) 18
levodopa - pharmacology (18) 18
substantia-nigra (18) 18
6-ohda (17) 17
levodopa - toxicity (17) 17
medicin och hälsovetenskap (17) 17
psychiatry (17) 17
serotonin (17) 17
l -dopa-induced dyskinesia (16) 16
medical and health sciences (16) 16
neurons (16) 16
parkinson disease - metabolism (16) 16
parkinsons disease (16) 16
article (15) 15
dihydroxyphenylalanine (15) 15
dopamine - metabolism (15) 15
model (15) 15
motor activity - drug effects (15) 15
motor complications (15) 15
neostriatum (15) 15
oxidopamine - toxicity (15) 15
parkinsonian disorders - drug therapy (15) 15
rodents (15) 15
disease (14) 14
dyskinesia, drug-induced - etiology (14) 14
l‐dopa‐induced dyskinesia (14) 14
medicinska och farmaceutiska grundvetenskaper (14) 14
parkinson disease - physiopathology (14) 14
antiparkinson agents - therapeutic use (13) 13
basic medicine (13) 13
corpus striatum - drug effects (13) 13
corpus striatum - metabolism (13) 13
dose-response relationship, drug (13) 13
health aspects (13) 13
messenger-rna (13) 13
mptp (13) 13
expression (12) 12
l-dopa (12) 12
neuroscience (12) 12
parkinson disease, secondary - chemically induced (12) 12
rat (12) 12
antiparkinson agents - toxicity (11) 11
biochemistry & molecular biology (11) 11
biomedicine (11) 11
levodopa - administration & dosage (11) 11
motor fluctuations (11) 11
neurovetenskaper (11) 11
synaptic plasticity (11) 11
5-ht (10) 10
behavior, animal - drug effects (10) 10
brain - metabolism (10) 10
dyskinesia, drug-induced - pathology (10) 10
gene expression (10) 10
induced motor complications (10) 10
phosphorylation (10) 10
physiological aspects (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Neuroscience, ISSN 0953-816X, 03/2019, Volume 49, Issue 6, pp. 869 - 882
Journal Article
Neuroscience, ISSN 0306-4522, 2012, Volume 211, pp. 13 - 27
Journal Article
Neurobiology of Aging, ISSN 0197-4580, 09/2019, Volume 81, pp. 190 - 199
Aging is a primary risk factor for the development of Parkinson's disease (PD), and aging differentially predicts the incidence of L-DOPA–induced dyskinesia... 
Aging | L-DOPA–induced dyskinesia | Neuroinflammation | Parkinson's disease | DOPAMINERGIC-NEURONS | MODEL | INTERLEUKIN-6 | CYTOKINE EXPRESSION | NEUROSCIENCES | GERIATRICS & GERONTOLOGY | MOTOR FLUCTUATIONS | LEVODOPA-INDUCED DYSKINESIA | DISEASE | GENE-EXPRESSION | L-DOPA-induced dyskinesia | ONSET | AGE | Phenols | Gene expression | Movement disorders | Risk factors | Psychophysiology
Journal Article
Neurochemistry International, ISSN 0197-0186, 03/2019, Volume 124, pp. 171 - 180
Parkinson's disease (PD) is a neurodegenerative disorder caused by the loss of dopaminergic neurons in the midbrain and shows motor dysfunctions. Zonisamide... 
L-DOPA–induced dyskinesia | Basal ganglia | Parkinson's disease | Zonisamide | PHARMACOLOGICAL VALIDATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | GLOBUS-PALLIDUS | NEUROSCIENCES | RAT MODEL | PALLIDAL NEURONS | NIGRA PARS-RETICULATA | SUBTHALAMIC NUCLEUS | MOUSE MODEL | MOTOR | L-DOPA-induced dyskinesia | CALCIUM-CHANNEL
Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 07/2011, Volume 118, Issue 1, pp. 12 - 23
J. Neurochem. (2011) 10.1111/j.1471‐4159.2011.07292.x l‐DOPA is the most commonly used treatment for symptomatic control in patients with Parkinson’s disease.... 
chronoamperometry | l‐DOPA‐induced dyskinesia | SERT | 5‐HT | 5-HT | l- DOPA-induced dyskinesia | IN-VIVO MICRODIALYSIS | EXTRACELLULAR DOPAMINE | BIOCHEMISTRY & MOLECULAR BIOLOGY | MODEL | 5-HT1A RECEPTOR STIMULATION | SUBSTANTIA-NIGRA | NEUROSCIENCES | EXOGENOUS L-DOPA | LEVODOPA-INDUCED DYSKINESIA | L-DOPA-induced dyskinesia | 6-HYDROXYDOPAMINE LESIONED RATS | STRIATUM | PARKINSONS-DISEASE | Severity of Illness Index | Tyrosine 3-Monooxygenase - metabolism | Dyskinesia, Drug-Induced - physiopathology | Presynaptic Terminals - drug effects | Stereotyped Behavior - drug effects | Rats | Levodopa - toxicity | Dyskinesia, Drug-Induced - pathology | Rats, Sprague-Dawley | Adrenergic Agents - toxicity | Dopa Decarboxylase - metabolism | Serotonin Plasma Membrane Transport Proteins - metabolism | Oxidopamine - toxicity | Animals | Apomorphine - pharmacology | Potassium Chloride - pharmacology | Serotonin - metabolism | Functional Laterality - drug effects | Presynaptic Terminals - metabolism | Female | Electrochemistry - methods | Corpus Striatum - pathology | Dopamine - metabolism | Disease Models, Animal | Phenols | Neurosciences | Dopamine | Parkinson's disease | Serotonin | Neurochemistry | Neurotransmitters | Side effects | Pharmacology | Parkinsons disease | Neurodegenerative diseases | Innervation | Neostriatum | Nerves | Levodopa | Movement disorders | Dyskinesia | Fibers | Chronoamperometry | L-DOPA induced dyskinesia | Basic Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper | Cell and Molecular Biology | Cell- och molekylärbiologi
Journal Article
Journal Article
Neuropharmacology, ISSN 0028-3908, 10/2018, Volume 141, pp. 260 - 271
Journal Article
Journal Article